Literature DB >> 3570400

Evaluation of the impact of screening for cancer of the cervix.

A B Miller.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3570400

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


× No keyword cloud information.
  7 in total

Review 1.  Efficacy of cervical cancer screening.

Authors:  F Pettersson
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

Review 2.  Use of the polymerase chain reaction to study the relationship between human papillomavirus infections and cervical cancer.

Authors:  W J Melchers; H C Claas; W G Quint
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

3.  Optimization of human papillomavirus genotype detection in cervical scrapes by a modified filter in situ hybridization test.

Authors:  W J Melchers; P Herbrink; J M Walboomers; C J Meijer; H vd Drift; J Lindeman; W G Quint
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

Review 4.  A screening programme that worked: discussion paper.

Authors:  M Hakama
Journal:  J R Soc Med       Date:  1990-05       Impact factor: 18.000

5.  Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.

Authors:  J M Walboomers; A M de Roda Husman; P J Snijders; H V Stel; E K Risse; T J Helmerhorst; F J Voorhorst; C J Meijer
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

6.  HR-HPV viral load quality detection provide more accurate prediction for residual lesions after treatment: a prospective cohort study in patients with high-grade squamous lesions or worse.

Authors:  Lihua Chen; Binhua Dong; Qiaoyu Zhang; Xiaodan Mao; Wenyu Lin; Guanyu Ruan; Yafang Kang; Pengming Sun
Journal:  Med Oncol       Date:  2020-03-30       Impact factor: 3.064

7.  Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation.

Authors:  L Gustafsson; H O Adami
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.